International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series: World’s leading Event Organizer


Recommended Conferences for Enzymosomes


As per available reports about 39 Relevant Journals, 37 Conferences, 12 Workshops are presently dedicated exclusively to enzymosomes and about 159 articles are being published on enzymosomes.

This hydrophobic enzyme, Ac-SOD, associated with liposomes (so called Ac-SOD-enzymosomes), is able to exert its therapeutic activity while circulating in the organism, regardless of the integrity of the liposomes. Ac-SOD-enzymosomes have a more rapid anti-inflammatory effect than SOD liposomes, confirming that the release of Ac-SOD from liposomes is no longer required to achieve dismutation.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance:

A theoretical advantage of the ‘immuno-enzymosomes’ over antibody-enzyme conjugates is that many more than one enzyme molecule can be included in one targeted carrier unit. Under the proper conditions, this may create the opportunity to increase the enzyme density at the tumor cell surface, which accordingly may lead to a more efficient conversion of the prodrug into the active cytotoxic parent compound. Earlier we have successfully prepared immuno-enzymosomes able to specifically bind in vitro to human ovarian carcinoma cells and subsequently convert the prodrugs epirubicin-glucuronide and daunorubicin-glucuronide into their toxic parent compounds.

The therapeutic proteins like enzymes can be delivered through several approaches such as using polymeric carriers; aqueous space of lipid and bilayered vesicles but their delivery by attachment on surface of liposomes has shown the prominent response for the development of antibodies at the target site. Enzymes upon complexing with lipids generate enzymosomes. Superoxide Dismutase (a therapeutic agent for oxidative stress related diseases like rheumatoid arthritis and ischaemia/reperfusion situations) loaded enzymosomes have been developed with long circulation time in the blood, in order to accumulate at inflammed target sites, while maintaining enzymatic activity in its intact form.

Antibody-directed enzyme prodrug therapy (ADEPT) is a two-step therapeutic approach designed to generate a high concentration of anticancer molecules only in close proximity to tumor cell membranes. The first step usually entails an antibody in an antibody–enzyme conjugate that binds to antigens preferentially expressed on tumor cells, or present in the tumor interstitium. The second step involves the injection of a nontoxic prodrug, which is matched with the enzyme, after completion of the enzyme targeting step and clearance of the conjugates from blood and normal tissues. Near the tumor cell membrane, the prodrug is converted into a cytotoxic drug by the targeted enzyme. At present, many ADEPT systems have been tested in preclinical settings and some are entering clinical trials. Recently, we proposed to improve ADEPT by using immuno liposomes as targeted carriers for the prodrug-activating enzymes (immuno-enzymosomes). 

Market Analysis:

The market for enzymosomes is expected to grow at a significant rate. Global Market is expected to reach USD 2.56 Billion by 2022. Constant technological advancements pertaining to the development to boost usage rates over the forecast period.

International symposium and workshops

  • 17th International HLA and Immunogenetics Workshop (IHIWS)
    Sep 6-10, 2017 Asilomar Conference Grounds in Pacific Grove, California
  • American Society of Histocompatibility and Immunogenetics (ASHI) 44th Annual Meeting Sep 11-15, 2017 in San Francisco, California
  • 2nd International Conference and Exhibition on Antibodies
    July 14-15, 2016 Philadelphia, USA

List of Best International Conferences:

  1. 6th Asia-Pacific Pharma Congress July 14-16, 2016 Kuala Lumpur, Malaysia
  2. Nanomedicine Conference July 25-27, 2016 Bangkok, Thailand
  3. 8th Pharmaceutics and Novel Drug Delivery Systems Conference 
    March 07-09, 2016 Madrid, Spain
  4. Industrial Pharmacy Conference April 28-29, 2016 Dubai, UAE
  5. 4th European Pharma Congress June 13-15, 2016 Berlin, Germany
  6. American Pharma Expo June 20-22, 2016 New Orleans, USA
  7. 4th Neuropharmacology Conference September 15-17, 2016 San Antonio, USA
  8. 2nd Pharma Middle East Congress October 12-14, 2016 Dubai, UAE
  9. 4th Clinical Pharmacy Conference Oct 31 - Nov 01, 2016 Las Vegas, USA
  10. 2nd Drug Discovery Conference Oct 31-Nov 02, 2016 Istanbul, Turkey
  11. World Congress and Exhibition on Antibiotics 
    September 14-16, 2015 Las Vegas, Nevada, USA
  12. 4th International Conference and Exhibition on Immunology 
    September 28-30, 2015 Houston, Texas, USA
  13. International Conference on Lipid Science & Technology 
    November 30-December 02, 2015 San Francisco, USA
  14. 3rd International Conference on Genomics & Pharmacogenomics 
    September 21-23, 2015 San Antonio, USA
  15. 4th International Conference on Clinical Microbiology and Microbial Genomics 
    October 05-07, 2015 Philadelphia, USA
  16. ICI 2015: 17th International Conference on Immunology 
    September 25 - 26, 2015 London, United Kingdom
  17. 4th European Congress of Immunology (ECI 2015) In Vienna, Austria
  18. British Society of Allergy and Clinical Immunology Annual Meeting 2015 
    September 4- 6, 2015 Telford, United Kingdom

Relevant Societies and Associations

  • American Autoimmune Related Diseases Association, USA
  • Lupus Foundation of America Inc., USA
  • National Multiple Sclerosis Society, USA
  • Australasian Society of Clinical Immunology and Allergy, Australia
  • Foundation for Sarcoidosis Research, USA
  • Graves ‘disease and Thyroid Foundation, USA
  • Immune Deficiency Foundation, USA
  • Lupus Research Institute, New York, USA
  • Multiple Sclerosis Association of America, USA
  • Multiple Sclerosis Foundation, USA
  • Myasthenia Gravis Foundation of America (MGFA), USA


  • Bristol-Myers Squibb
  • Daiichi Sankyo
  • Hisamitsu
  • Johnson & Johnson
  • Merck & Co
  • Mitsubishi Tanabe
  • Novartis
  • Pfizer
  • AbbVie
  • Amgen
  • Astellas

This page will be updated regularly.

This page was last updated on 18th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
[email protected]
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
[email protected]
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
[email protected]
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
[email protected]
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
[email protected]
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
[email protected]
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
[email protected]
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
[email protected]
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
[email protected]
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
[email protected]
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
[email protected]
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
[email protected]
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
[email protected]
+1-702-508-5200 Ext:8051

Program Enquiries
Media Partners | Advertising